Umeclidinium and Vilanterol Trifenatate (Anoro Ellipta)
Questions a plan sponsor actually asks.
What is Umeclidinium and Vilanterol Trifenatate used for?
Umeclidinium and Vilanterol Trifenatate is tracked in Medicare Part D. Specific indication information is not available in our current dataset.
Is there a generic for Umeclidinium and Vilanterol Trifenatate?
No. Umeclidinium and Vilanterol Trifenatate is brand-only with no generic equivalents currently in market.
How much does my plan pay for Umeclidinium and Vilanterol Trifenatate?
Across 329 Part D plans, Umeclidinium and Vilanterol Trifenatate averages $6.93/unit (NADAC). Lowest available: $4.95/unit. Highest in distribution: $8.03/unit.
Is Umeclidinium and Vilanterol Trifenatate on the FDA shortage list?
No. Umeclidinium and Vilanterol Trifenatate is not currently on the FDA Drug Shortage Database.
5 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.
Sources · every number above traces back.
Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (6 approvals on file) · NADAC unit costs: CMS NADAC weekly file (3 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.